miR-155 promotes FLT3-ITD–induced myeloproliferative disease through inhibition of the interferon response

Jared A. Wallace, Dominique A. Kagele, Anna M. Eiring, Carissa N. Kim, Ruozhen Hu, Marah C. Runtsch, Margaret Alexander, Thomas B. Huffaker, Soh-Hyun Lee, Ami B. Patel, Timothy L. Mosbruger, Warren P. Voth, Dinesh S. Rao, Rodney R. Miles, June L. Round, Michael W. Deininger and Ryan M. O’Connell